Piperidinesulfonylurea derivatives

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31505

Patent

active

040525074

ABSTRACT:
A series of novel 1-piperidinesulfonylurea compounds derived from a pyrimidine monocarboxylic acid have been prepared by reacting an appropriate sulfamide with an organic isocyanate or a trisubstituted urea equivalent thereof. The sulfamylureas so obtained are useful in therapy as oral hypoglycemic agents. Typical members include those compounds derived from 1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione-5-carboxylic acid, of which 1-(bicyclo[2.2.1]hept-5-en-2-yl-endo-methyl)-3-{4-[2-(1,3-dimethyl-1,2,3,4 -tetrahydropyrimidine-2,4-dione-5-carboxamido)ethyl]-1-piperidinesulfonyl}u rea is a most preferred embodiment.

REFERENCES:
patent: 3705899 (1972-12-01), Regniev et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Piperidinesulfonylurea derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidinesulfonylurea derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidinesulfonylurea derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1775503

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.